Antheia is a U.S.-based next-generation pharmaceutical ingredient manufacturer using advanced biosynthesis (yeast fermentation) to produce Key Starting Materials (KSMs) and APIs. They partner with companies like TAPI and Phlow Corp to commercialize biosynthetic pharmaceutical ingredients, focusing on addressing drug shortages through domestic biomanufacturing.
biosynthesis of pharmaceutical ingredients, yeast fermentation platform, Key Starting Materials (KSMs), drug shortage solutions, advanced biomanufacturing
1 site worldwide
No reviews available yet.
No documents available.